A bill that would expand access to a discount drug program known as 340B could end up costing the state more than $43 million ...

Small business owners are struggling to keep up with the rising cost of healthcare. Nearly a third have recently stopped ...

Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among drugmakers, ...

Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...

Scaling 340B compliance Mercy Medical Center automated audits to recapture missed savings and ensure full claim coverage across 30+ clinics.

As regulatory scrutiny increases and manufacturer restrictions continue to evolve, Halo 340B provides an intelligent safety net that transforms 340B management from a high-risk administrative burden ...

Hospitals are suing to block a Trump administration pilot that will allow drugmakers to issue post-sale rebates instead of upfront discounts on medications in the 340B drug discount program, arguing ...

Minnesota's 340B drug discount program faces scrutiny as small clinics struggle and large hospitals profit, sparking ...

On December 29, 2025—just three days before the 340B Rebate Model Pilot Program (the Rebate Program) was set to begin—the U.S. District Court for the District of Maine issued an order granting a ...

Community-based practices are under increasing pressure to sell or close due to the unintended consequences of a rapidly ...

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...